Next Article in Journal
Analysis of the Phenolic Profile of Chelidonium majus L. and Its Combination with Sericin: Balancing Antimicrobial Activity and Cytocompatibility
Previous Article in Journal
Triglycerides, Glucose Metabolism, and Type 2 Diabetes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Magnesium Preserves Calcium Homeostasis and Contributes to Protect Myotubes from Inflammation-Induced Damage

by
Giuseppe Pietropaolo
1,2,*,
Sara Castiglioni
3,
Jeanette A. Maier
3,
Federica I. Wolf
1 and
Valentina Trapani
1,4
1
Dipartimento di Medicina e Chirurgia Traslazionale, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
2
IRCCS Neuromed, 86077 Pozzilli, Italy
3
Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, 20157 Milan, Italy
4
Departmental Faculty of Medicine, UniCamillus, Saint Camillus International University of Medical Sciences, 00131 Rome, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(20), 9912; https://doi.org/10.3390/ijms26209912
Submission received: 5 September 2025 / Revised: 3 October 2025 / Accepted: 9 October 2025 / Published: 11 October 2025
(This article belongs to the Section Molecular Immunology)

Abstract

Magnesium (Mg2+) is a key regulator of cellular biochemical processes and an essential cofactor in skeletal muscle physiology. Although Mg2+ deficiency has been linked to reduced muscle strength, its role in the regulation of calcium (Ca2+) signaling and in inflammation remains incompletely understood. In this study, we examined the effects of Mg2+ availability using the murine myoblast cell line C2C12. Cells were differentiated under low, normal, or high Mg2+ conditions, and myotube formation, intracellular Ca2+ fluxes, and resistance to inflammatory stimuli were assessed. Mg2+ deficiency impaired myotube differentiation, while Mg2+ supplementation preserved Ca2+ response during stimulation and contributed to protect myotubes against inflammation-induced damage. Collectively, these findings highlight a dual role of Mg2+ in sustaining functional performance under repeated stress and protecting myotubes against inflammatory injury. This study supports the importance of adequate dietary Mg2+ intake as a potential strategy to mitigate muscle loss associated with aging and chronic inflammation.

1. Introduction

Mg2+, the second intracellular cation by concentration, is one of the most abundant macronutrients in the human body. It plays a crucial role in cellular function, being involved in over 600 enzymatic reactions and numerous metabolic pathways [1]. Approximately 90% of intracellular Mg2+ is bound, while free Mg2+ concentration ranges from 0.5 to 1.1 mmol/L, which is comparable to serum concentration. The body contains roughly 25 g of Mg2+, primarily stored in bone, muscle and other soft tissues [2].
Systemic Mg2+ homeostasis depends on concomitant action of intestinal absorption from food and renal regulation of excretion and reabsorption [1]. Mg2+ is absorbed through different and concomitant mechanisms: a passive paracellular transport driven by electrochemical gradient and an active transcellular transport mediated by two homologous channels, the transient receptor potential melastatin (TRPM) 6 and 7 [3,4].
Mg2+ prevents the dangerous effects of reactive oxygen species (ROS) by inhibiting their production in granulocytes, reducing mast cell degranulation [5], and acting as an anti-inflammatory agent [6]. Studies in animal models demonstrate that low Mg2+ levels induce signs of inflammation and an increase in pro-inflammatory cytokines, i.e., IL-1β, TNF-α and IL-6 [5,7]. Several studies have demonstrated that subclinical Mg2+ deficiency is associated with elevated levels of C-reactive protein (CRP) and a low-grade inflammatory state, which represents a primum movens in the development of various pathological conditions, including cardiovascular disease, metabolic syndrome, osteoporosis, and asthma [8].
Mg2+ plays a pivotal role in skeletal muscle physiology and cellular metabolism. Hypomagnesemia has been associated with increased muscle hyperexcitability, hypercontractility, and the occurrence of cramps [9]. During myofiber differentiation, intracellular Mg2+ concentration decreases, returning to baseline levels at the end of the differentiation process. This reduction is associated with the downregulation of Mg2+ transporters, including magnesium transporter 1 (MagT1) and TRPM7, whose expression remains suppressed even in fully differentiated cells [10]. Throughout this process, Ca2+ levels play a critical role: elevated Mg2+ concentrations, by altering the intracellular Ca2+/Mg2+ ratio, promote the formation of larger myotubes compared to those differentiated under low Mg2+ [9]. At the cellular level, Mg2+ acts as a Ca2+ antagonist, sharing the Ca2+ binding site on troponin C (TnC) with a significantly lower affinity. Under resting conditions, intracellular Mg2+ concentrations exceed those of Ca2+, allowing Mg2+ to occupy the Ca2+/Mg2+ binding sites on TnC, thereby stabilizing the relaxed state of the muscle fiber. Following membrane depolarization, Ca2+ is rapidly released from the sarcoplasmic reticulum (SR) and replaces Mg2+ at TnC binding sites, triggering the contractile response [11]. Moreover, Mg2+ is essential for the proper functions of both ryanodine receptors (RyRs), which mediate Ca2+ release, and the sarco-endoplasmic reticulum Ca2+ ATPase (SERCA), which regulates Ca2+ reuptake into the sarcoplasmic reticulum [12].
In vivo and in vitro studies have shown that non-physiological Mg2+ levels lead to reduced muscle mass in animal models, accompanied by increased oxidative stress markers and impaired differentiation of muscle stem cells, highlighting the pivotal role of Mg2+ in muscle biology [13,14].
In humans, low serum Mg2+ levels have been associated with impaired physical performance [15]. A putative protective role for Mg2+ in sarcopenia, a common age-associated degenerative muscle condition, has been proposed. Oral Mg2+ supplementation has been shown to attenuate muscle damage, potentially reduce intramuscular fat infiltration, and is correlated with lower levels of systemic inflammatory biomarkers [16]. Furthermore, elevated circulating Mg2+ concentrations in older individuals have been associated with enhanced muscle function, likely due to the role of Mg2+ in mitochondrial energy metabolism and its capacity to counteract ROS-induced damage [17]. Consistently, supplementation with magnesium oxide has also been shown to improve physical performance in elderly populations [18].
Despite the well-established roles of Mg2+ in maintaining muscle homeostasis, several aspects remain unclear. For instance, does Mg2+ modulate Ca2+ signaling and influence myofiber differentiation? Could Mg2+ confer protection against muscle injury? In this study, by using an in vitro model, we highlight previously unrecognized functions of Mg2+ in preserving muscle responsiveness to depolarizing signals, and in protecting muscle tissue from inflammatory stimuli.

2. Results

2.1. Mg2+ Availability Affects Myotube Differentiation

C2C12 cells can differentiate in vitro, fusing into multinucleated myotubes once confluence is reached and serum is withdrawn. We investigated whether Mg2+ availability in the culture medium influences this differentiation process. As expected, reduced Mg2+ levels impaired cell proliferation (Figure 1A). Therefore, cells were cultured under normal Mg2+ concentrations until reaching confluence, and Mg2+ conditions were modified only at the onset of differentiation. As shown in Figure 1B,C, Mg2+ deficiency significantly decreased both the number and size of myotubes. In contrast, differentiation in high Mg2+ levels resulted in a slightly lower number of myotubes, which did not significantly differ from the control. The Mg2+ concentrations used (0.1 and 5 mM) are widely used to model Mg2+ deficiency and supplementation, respectively.

2.2. Mg2+ Availability Affects Ca2+ Release from the SR

Excitation–contraction coupling in skeletal muscle fibers relies on rapid communication between membrane depolarization events and Ca2+ release from the SR. Experimentally, membrane depolarization can be induced by increasing the extracellular K+ concentration. Upon KCl addition, a rapid and transient rise in intracellular Ca2+ concentration occurs, followed by a prompt return to baseline levels. The kinetics can be visualized and quantified using live imaging of Fluo-4-loaded cells (see Supplementary Materials, Video S1). We analyzed the kinetics of the Ca2+ response in myotubes differentiated under low, normal or high Mg2+ conditions. As shown in Figure 2, while the overall kinetics of the Ca2+ flux did not differ significantly across conditions, the amplitude of the Ca2+ signal positively correlated with Mg2+ availability. Specifically, myotubes differentiated in Mg2+-deficient medium exhibited a significantly attenuated Ca2+ response than those differentiated in Mg2+-supplemented conditions.

2.3. Mg2+ Availability Impairs Intracellular Ca2+ Store Refilling

Restoration of baseline intracellular Ca2+ levels following excitation–contraction relies on several mechanisms, including active reuptake into the SR. To evaluate the ability of myotubes to sustain repeated cycles of excitation–contraction, we stimulated the same myotubes with KCl, allowed a recovery period of 10 min between stimulations and repeated this protocol three times. As shown in Figure 3, myotubes that had differentiated in control or Mg2+-supplemented media maintained a consistent Ca2+ response across repeated stimulations. In contrast, myotubes derived from Mg2+-deficient cultures exhibited a markedly reduced initial Ca2+ response, which declined even further with successive stimulations, indicating impaired Ca2+ handling capacity.

2.4. Mg2+ Availability Affects Myotube Resistance to Inflammatory Stimuli

Numerous studies have reported the anti-inflammatory properties of Mg2+ [5,7,8]. To assess this protective effective of Mg2+ in the context of muscular physiology, we conducted preliminary experiments in the C2C12 model and challenged myotubes differentiated under low, normal and high Mg2+ conditions with TNF-α, a prototypical pro-inflammatory stimulus (representative images of myotubes prior to treatment are shown in Supplementary Figure S1). As expected, TNF-α treatment markedly disrupted myotubes in both low-Mg2+ and control conditions. Notably, myotubes differentiated in high-Mg2+ medium appeared largely resistant to TNF-α-induced damage, retaining their morphology and overall integrity (Figure 4A–C). In line with these observations, TNF-α exposure was associated with a more pronounced decrease in myostatin expression—a negative regulator of muscle cell proliferation—in cultures under high Mg2+ concentrations (Figure 4D).

3. Discussion

Mg2+ is an important macronutrient involved in a plethora of pathophysiological processes including oxidative stress regulation, inflammation, and muscle metabolism [1]. Previous findings have indicated that extracellular Mg2+ levels influence muscle fiber formation, primarily through modulation of oxidative stress [14]. Consistent with these findings, our results confirm that low Mg2+ availability impairs myotube differentiation (Figure 1B), and introduce two novel insights: first, Mg2+ availability plays a critical role in preserving functional performance (Figure 2 and Figure 3); and second, Mg2+ supplementation confers protection from inflammation-induced myotube disruption (Figure 4). Our findings partially contrast with previous reports suggesting that also Mg2+ supplementation can impair C2C12 myotube differentiation [14]. In our experiments, myotubes differentiated in high Mg2+ levels were slightly fewer in number, but this difference did not reach statistical significance compared to controls. This discrepancy may stem from variations in the experimental design, including the Mg2+ concentrations applied, the composition of differentiation media, and the timing of supplementation. Notably, we observed that myotubes differentiated under high Mg2+ levels (5 mM) displayed no differences compared to those cultured under normal concentrations (0.8 mM), indicating that supraphysiological Mg2+ concentrations do not further promote differentiation over baseline conditions. In line with our in vitro observations, in vivo studies have shown that subclinical Mg2+ deficiency alters muscle fiber characteristics, downregulates Mg2+ transporters, and disrupts the expression of genes involved in muscle physiology, metabolism, and regeneration [19].
From a functional perspective, our data indicate for the first time that different Mg2+ levels critically influence Ca2+ handling in differentiated myotubes. Although the kinetics of Ca2+ transients induced by membrane depolarization were comparable across groups, the amplitude of the Ca2+ response was markedly reduced under Mg2+ deficiency. Notably, during repeated depolarization cycles, Mg2+-deficient myotubes exhibited a progressive decline in Ca2+ release capacity, suggesting compromised sustainability of excitation–contraction coupling.
This phenotype likely reflects alterations in key components of the excitation–contraction coupling machinery, particularly RyRs, which mediate Ca2+ release from the SR to initiate troponin activation and force generation, and SERCAs, which pump Ca2+ back into the SR against its concentration gradient [20]. Mg2+ is indispensable for the proper function of both RyRs and SERCAs [12,21]. Mg2+ serves as a key regulator of RyRs function, acting both as an essential cofactor for ATP-dependent regulation and as a physiological inhibitor of uncontrolled Ca2 leak from the SR. Under Mg2+ deficiency, RyRs channels may display altered gating behavior, leading to diminished Ca2+ release upon depolarization or enhanced basal leak, thereby reducing SR Ca2+ content available for subsequent contractions. In parallel, Mg2+ is essential for the activity of SERCAs, since ATP binding and hydrolysis are Mg2+-dependent. Insufficient Mg2+ may therefore impair SERCA-mediated Ca2+ reuptake, slowing relaxation and progressively depleting SR Ca2+ stores during repeated stimulation. Studies in rats fed an Mg2+-deficient diet reported increased RyRs sensitivity to Ca2+ and impaired Ca2+-ATPase activity in isolated SR, leading to Ca2+ overload [22]. The functional impairments we observed may also involve store-operated Ca2+ entry (SOCE), a pathway essential for refilling SR Ca2+ stores, which is known to decline in aged skeletal muscle contributing to reduced contractile force [23,24]. Mg2+ is essential for mitochondrial function, sustaining electron transport chain activity and ATP synthesis [1]. Deficiency leads to mitochondrial damage and increased ROS production [25], which, in turn, can impair Ca2+/Mg2+ homeostasis and exacerbate RyR and SERCA dysfunction, ultimately reducing Ca2+ release capacity during repeated stimulation.
We also demonstrate that Mg2+ supplementation protects skeletal muscle cells against inflammation-induced damage (Figure 4), in agreement with its well-documented anti-inflammatory properties [5,26] and with epidemiological evidence linking low dietary Mg2+ intake to accelerated skeletal muscle mass loss across multiple cohorts [16,27,28]. In our model, myoblasts differentiated under high Mg2+ concentrations were uniquely resistant to TNF-α-induced damage, whereas cells cultured under normal or deficient Mg2+ levels were highly susceptible. Mechanistically, the anti-inflammatory role of Mg2+ has been attributed to multiple pathways, including the suppression of ROS generation, the inhibition of NF-κB signaling, and the consequent reduction in the expression of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α [6,7]. These pathways are central to the cascade leading to muscle damage during inflammation, and Mg2+ could act at nodal regulatory points to mitigate cellular injury. Beyond acute protection, Mg2+ may also contribute to long-term muscle preservation by maintaining redox balance, stabilizing mitochondrial function, and modulating calcium homeostasis, processes that are critical for sustaining muscle integrity under inflammatory challenges [6,7,29].
Previous studies have shown that the effects of TNF-α on C2C12 cells are dose-dependent. Low to intermediate TNF-α doses markedly impair differentiation by downregulating key myogenic factors, upregulating catabolic genes, promoting atrophy, without causing significant cytotoxicity [30,31,32,33]. At higher concentrations (≥50 ng/mL), TNF-α triggers pronounced myotube atrophy and apoptosis, accompanied by a substantial loss of contractile proteins [34,35,36]. In our preliminary study, designed to evaluate the impact of Mg2+ supplementation during inflammation-induced injury, we used an intermediate TNF-α dose to mimic the pauci-inflammatory conditions typically observed in pathological contexts, where Mg2+ has been reported to exert protective effects. Notably, we found that, after TNF-α treatment, myostatin expression was reduced in myotubes differentiated under high Mg2+ concentrations, compared with those differentiated under low or normal Mg2+ levels. These results suggest that elevated Mg2+ availability may enhance the resilience of muscle cells to inflammatory stress and potentially support their proliferative capacity. Further studies are required to clarify the molecular mechanisms underlying this protective effect and to determine whether Mg2+ primarily counteracts apoptosis, atrophy, or both. Future work should also address the potentially different sensitivity of differentiated myotubes compared with undifferentiated cells to inflammatory stimuli. Finally, an important aspect not examined in this study is the role of Ca2+ fluxes under inflammatory conditions. Exploring the interplay between Mg2+ and Ca2+ homeostasis, using complementary methodological approaches, will be crucial to better understand their cooperative contribution to muscle cell responses [37].
Translationally, our findings suggest that Mg2+ deficiency impairs excitation–contraction coupling and Ca2+ handling in differentiated muscle cells in vitro, process that may contribute to age-associated alteration in muscle physiology. In older adults or in individuals with chronic or metabolic conditions, Mg2+ deficiency may further exacerbate oxidative stress, disturbed Ca2+ homeostasis, muscle wasting and frailty. Low dietary Mg2+ intake and reduced serum Mg2+ levels have contributed to poorer physical performance, decreased muscle strength, and a higher prevalence of sarcopenia in older adults [15,17,38]. Mg2+ deficiency is also associated with low-grade chronic inflammation [39,40], which may further accelerate muscle catabolism. Importantly, the improvements in muscle performance observed following Mg2+ supplementation in older individuals [18] may be related to mechanisms such as preserved Ca2+ handling and protection against inflammation-induced atrophy, as observed in our in vitro model.
In conclusion, while this work was conducted in a single in vitro model and did not include additional mechanistic assays, our results underscore the central role of Mg2+ in skeletal muscle biology demonstrating for the first time that adequate Mg2+ availability is essential in maintaining a correct Ca2+ response to repeated stimulation. Mg2+ is critical for myogenesis, the maintenance of calcium homeostasis, and protection against inflammatory stress in C2C12 muscle cells in vitro. While further studies in complementary models and clinical settings are needed to validate and extend our observations, the present results collectively support the idea that adequate Mg2+ intake through diet, or supplementation when appropriate, may help maintain muscle health. Based on our in vitro experiments, Mg2+ supplementation may represent a practical, safe, low-cost, and effective nutritional strategy to support muscle cell function and resilience to inflammatory stress.

4. Materials and Methods

4.1. Cell Culture and Differentiation

C2C12 murine skeletal muscle myoblasts were maintained in high-glucose Dulbecco’s Modified Eagle Medium (DMEM; EuroClone, Pero, Italy), supplemented with 20% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, and 100 U/mL penicillin-streptomycin. Cultures were kept at 37 °C in a humidified atmosphere with 5% CO2 and used between passages 8 and 12.
To induce differentiation, cells were grown to confluence and then switched to a differentiation medium composed of high-glucose magnesium-free DMEM (Invitrogen, Waltham, MA, USA), 1% FBS, 2 mM L-glutamine, and 1% penicillin-streptomycin. Magnesium sulfate (MgSO4) was added to achieve the desired final Mg2+ concentrations: 0.1 mM (low), 0.8 mM (normal), or 5 mM (high). Cultures were maintained in differentiation medium for eight days; with medium replaced twice daily to maintain optimal conditions. On day 7, to simulate an inflammatory environment, differentiated cultures were exposed for 24 h to recombinant mouse TNF-α (PeproTech, Cranbury, NJ, USA) at a final concentration of 25 ng/mL. Images of cultured cells were acquired at 10× magnification using an Eclipse TE-2000-S microscope (Nikon Instruments, Campo Bisenzio, FI, Italy). Myotubes were counted in brightfield (phase contrast) images. Image analysis was performed with ImageJ software, version 1.54f. For each experiment, three independent microscopic fields were evaluated. All experiments were performed independently three times, each in duplicate, with similar results.

4.2. Western Blot

Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.05% sodium deoxycholate, and 0.1% SDS), supplemented with protease and phosphatase inhibitors (10 µg/mL leupeptin, 20 µg/mL aprotinin, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, and 100 mM sodium fluoride). Protein concentration was determined using the Bradford assay (Bio-Rad Laboratories Srl., Segrate (MI), Italy). Equal amounts of protein (50 µg) were separated by 8% SDS-PAGE and transferred onto polyvinylidene difluoride (PVDF) membranes. Membranes were incubated with rabbit polyclonal anti-actin primary antibodies (1:1000, Sigma-Aldrich Srl., Milan, Italy). After stripping with a buffer containing 1 M Tris-HCl (pH 6.8), 10% SDS, and β-mercaptoethanol, membranes were re-probed with rabbit polyclonal anti-myostatin antibodies (1:500, Abcam Ltd., Cambridge, UK). Detection was performed using horseradish peroxidase-conjugated secondary antibodies (GE Healthcare Srl., Milan, Italy) and enhanced chemiluminescence with the ECL Prime Western Blotting Detection Reagent (GE Healthcare Srl., Milan, Italy). Chemiluminescent signals were visualized using the ChemiDoc XRS system (Bio-Rad Laboratories Srl., Segrate (MI), Italy).

4.3. Calcium Measurements

C2C12 cells were seeded and differentiated on 35-mm glass-bottom microscopy dishes (Ibidi GmbH, Gräfelfing, Germany), as previously described. For imaging, cells were incubated with 3 µM Fluo-4 AM (Thermo Fisher Scientific, Waltham, MA, USA), a fluorescent calcium indicator, and maintained in a Na+, Ca2+, and Mg2+-free buffer during imaging.
Live-cell imaging was performed using a confocal system Leica TCS SP5 (Tokyo, Japan). The baseline was monitored for 15 s, then KCl 50 mM was added dropwise to induce membrane depolarization. Changes in intracellular calcium levels were quantified by measuring the relative increase in fluorescence intensity (ΔF/F). Image analysis was performed by Leica Confocal Software LCS Lite 2.61.1537, and 10 representative myotubes were examined in each microscopic field. Experiments were repeated independently three times with similar results.

4.4. Statistical Analysis

Prism software (version 9.3.1, GraphPad Software Inc., La Jolla, CA, USA) was used for statistical analyses. Statistical significance was evaluated using unpaired Student’s t-test or one-way ANOVA, followed by Bonferroni’s test. Differences were considered statistically significant for p values < 0.05.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms26209912/s1.

Author Contributions

Conceptualization, G.P. and V.T.; methodology, G.P. and V.T.; formal analysis, G.P., S.C. and V.T.; investigation, G.P. and V.T.; writing—original draft preparation, G.P. and V.T.; writing—review and editing, G.P., S.C., J.A.M., F.I.W. and V.T.; supervision, F.I.W. and V.T.; funding acquisition, F.I.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by MIUR (Italian Ministry of University and Research) D.3.2.2015 and D.1.2017.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The row data supporting the conclusion of this article will be made available by the authors on request.

Acknowledgments

Confocal imaging was performed at the LABCEMI (Laboratorio Centralizzato di Microscopia Ottica ed Elettronica), Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS, Rome, Italy. PNRR-MAD-2022-12375947, Next Generation EU—PNRR M6C2—Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN funds fellowship to G.P.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. De Baaij, J.H.F.; Hoenderop, J.G.J.; Bindels, R.J. Magnesium in Man: Implications for Health and Disease. Physiol. Rev. 2015, 95, 1–46. [Google Scholar] [CrossRef] [PubMed]
  2. Touyz, R.M.; de Baaij, J.H.F.; Hoenderop, J.G.J. Magnesium Disorders. N. Engl. J. Med. 2024, 390, 1998–2009. [Google Scholar] [CrossRef] [PubMed]
  3. Schlingmann, K.P.; Waldegger, S.; Konrad, M.; Chubanov, V.; Gudermann, T. TRPM6 and TRPM7—Gatekeepers of human magnesium metabolism. Biochim. Biophys. Acta (BBA)—Mol. Basis Dis. 2007, 1772, 813–821. [Google Scholar] [CrossRef] [PubMed]
  4. Luongo, F.; Pietropaolo, G.; Gautier, M.; Dhennin-Duthille, I.; Ouadid-Ahidouch, H.; Wolf, F.I.; Trapani, V. TRPM6 is Essential for Magnesium Uptake and Epithelial Cell Function in the Colon. Nutrients 2018, 10, 784. [Google Scholar] [CrossRef]
  5. Maier, J.A.; Castiglioni, S.; Locatelli, L.; Zocchi, M.; Mazur, A. Magnesium and inflammation: Advances and perspectives. Semin. Cell Dev. Biol. 2021, 115, 37–44. [Google Scholar] [CrossRef]
  6. Trapani, V.; Petito, V.; Di Agostini, A.; Arduini, D.; Hamersma, W.; Pietropaolo, G.; Luongo, F.; Arena, V.; Stigliano, E.; Lopetuso, L.R.; et al. Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel. Inflamm. Bowel Dis. 2018, 24, 2198–2210. [Google Scholar] [CrossRef]
  7. Ashique, S.; Kumar, S.; Hussain, A.; Mishra, N.; Garg, A.; Gowda, B.H.J.; Farid, A.; Gupta, G.; Dua, K.; Taghizadeh-Hesary, F. A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer. J. Health Popul. Nutr. 2023, 42, 74, Erratum in J. Health Popul. Nutr. 2023, 42, 117. [Google Scholar] [CrossRef]
  8. Mazidi, M.; Rezaie, P.; Banach, M. Effect of magnesium supplements on serum C-reactive protein: A systematic review and meta-analysis. Arch. Med. Sci. 2018, 14, 707–716. [Google Scholar] [CrossRef]
  9. Castiglioni, S.; Mazur, A.; Maier, J.A. The central role of magnesium in skeletal muscle: From myogenesis to performance. Magnes. Res. 2024, 37, 1–11. [Google Scholar] [CrossRef]
  10. Zocchi, M.; Locatelli, L.; Zuccotti, G.V.; Mazur, A.; Béchet, D.; Maier, J.A.; Castiglioni, S. Magnesium Homeostasis in Myogenic Differentiation—A Focus on the Regulation of TRPM7, MagT1 and SLC41A1 Transporters. Int. J. Mol. Sci. 2022, 23, 1658. [Google Scholar] [CrossRef]
  11. Konishi, M. Cytoplasmic Free Concentrations of Ca2+ and Mg2+ in Skeletal Muscle Fibers at Rest and during Contraction. Jpn. J. Physiol. 1998, 48, 421–438. [Google Scholar] [CrossRef]
  12. Dias, J.M.; Szegedi, C.; Jóna, I.; Vogel, P.D. Insights into the Regulation of the Ryanodine Receptor: Differential Effects of Mg2+ and Ca2+ on ATP Binding. Biochemistry 2006, 45, 9408–9415. [Google Scholar] [CrossRef]
  13. Furutani, Y.; Funaba, M.; Matsui, T. Magnesium deficiency up-regulates Myod expression in rat skeletal muscle and C2C12 myogenic cells. Cell Biochem. Funct. 2011, 29, 577–581. [Google Scholar] [CrossRef]
  14. Zocchi, M.; Béchet, D.; Mazur, A.; Maier, J.A.; Castiglioni, S. Magnesium Influences Membrane Fusion during Myogenesis by Modulating Oxidative Stress in C2C12 Myoblasts. Nutrients 2021, 13, 1049. [Google Scholar] [CrossRef] [PubMed]
  15. Lukaski, H.C. Magnesium, zinc, and chromium nutriture and physical activity. Am. J. Clin. Nutr. 2000, 72, 585S–593S. [Google Scholar] [CrossRef]
  16. Yang, S.-W.; Chen, Y.-Y.; Chen, W.-L. Association between oral intake magnesium and sarcopenia: A cross-sectional study. BMC Geriatr. 2022, 22, 1–8. [Google Scholar] [CrossRef]
  17. Barbagallo, M.; Dominguez, L. Magnesium and Aging. Curr. Pharm. Des. 2010, 16, 832–839. [Google Scholar] [CrossRef]
  18. Veronese, N.; Berton, L.; Carraro, S.; Bolzetta, F.; De Rui, M.; Perissinotto, E.; Toffanello, E.D.; Bano, G.; Pizzato, S.; Miotto, F.; et al. Effect of oral magnesium supplementation on physical performance in healthy elderly women involved in a weekly exercise program: A randomized controlled trial. Am. J. Clin. Nutr. 2014, 100, 974–981. [Google Scholar] [CrossRef] [PubMed]
  19. Bayle, D.; Coudy-Gandilhon, C.; Gueugneau, M.; Castiglioni, S.; Zocchi, M.; Maj-Zurawska, M.; Palinska-Saadi, A.; Mazur, A.; Béchet, D.; Maier, J.A. Magnesium Deficiency Alters Expression of Genes Critical for Muscle Magnesium Homeostasis and Physiology in Mice. Nutrients 2021, 13, 2169. [Google Scholar] [CrossRef] [PubMed]
  20. Xu, H.; Van Remmen, H. The SarcoEndoplasmic Reticulum Calcium ATPase (SERCA) Pump: A Potential Target for Intervention in Aging and Skeletal Muscle Pathologies. Skelet. Muscle 2021, 11, 25. [Google Scholar] [CrossRef] [PubMed]
  21. Nielsen, F.H.; Lukaski, H.C. Update on the relationship between magnesium and exercise. Magnes. Res. 2006, 19, 180–189. [Google Scholar]
  22. Astier, C.; Rock, E.; Lab, C.; Gueux, E.; Mazur, A.; Rayssiguier, Y. Functional alterations in sarcoplasmic reticulum membranes of magnesium-deficient rat skeletal muscle as consequences of free radical-mediated process. Free Radic. Biol. Med. 1996, 20, 667–674. [Google Scholar] [CrossRef] [PubMed]
  23. Edwards, J.N.; Blackmore, D.G.; Gilbert, D.F.; Murphy, R.M.; Launikonis, B.S. Store-operated calcium entry remains fully functional in aged mouse skeletal muscle despite a decline in STIM1 protein expression. Aging Cell 2011, 10, 675–685. [Google Scholar] [CrossRef]
  24. Thornton, A.M.; Zhao, X.; Weisleder, N.; Brotto, L.S.; Bougoin, S.; Nosek, T.M.; Reid, M.; Hardin, B.; Pan, Z.; Ma, J.; et al. Store-Operated Ca2+ Entry (SOCE) Contributes to Normal Skeletal Muscle Contractility in young but not in aged skeletal muscle. Aging 2011, 3, 621–634. [Google Scholar] [CrossRef] [PubMed]
  25. Rock, E.; Astier, C.; Lab, C.; Vignon, X.; Gueux, E.; Motta, C.; Rayssiguier, Y. Dietary Magnesium Deficiency in Rats Enhances Free Radical Production in Skeletal Muscle. J. Nutr. 1995, 125, 1205–1210. [Google Scholar] [CrossRef] [PubMed]
  26. Cepeda, V.; Ródenas-Munar, M.; García, S.; Bouzas, C.; Tur, J.A. Unlocking the Power of Magnesium: A Systematic Review and Meta-Analysis Regarding Its Role in Oxidative Stress and Inflammation. Antioxidants 2025, 14, 740. [Google Scholar] [CrossRef] [PubMed]
  27. Welch, A.A.; Kelaiditi, E.; Jennings, A.; Steves, C.J.; Spector, T.D.; MacGregor, A. Dietary Magnesium Is Positively Associated With Skeletal Muscle Power and Indices of Muscle Mass and May Attenuate the Association Between Circulating C-Reactive Protein and Muscle Mass in Women. J. Bone Miner. Res. 2015, 31, 317–325. [Google Scholar] [CrossRef]
  28. Villa-Bellosta, R. Dietary magnesium supplementation improves lifespan in a mouse model of progeria. EMBO Mol. Med. 2020, 12, e12423. [Google Scholar] [CrossRef]
  29. Shah, N.C.; Liu, J.-P.; Iqbal, J.; Hussain, M.; Jiang, X.-C.; Li, Z.; Li, Y.; Zheng, T.; Li, W.; Sica, A.C.; et al. Mg deficiency results in modulation of serum lipids, glutathione, and NO synthase isozyme activation in cardiovascular tissues: Relevance to de novo synthesis of ceramide, serum Mg and atherogenesis. Int. J. Clin. Exp. Med. 2011, 4, 103–118. [Google Scholar]
  30. De Larichaudy, J.; Zufferli, A.; Serra, F.; Isidori, A.M.; Naro, F.; Dessalle, K.; Desgeorges, M.; Piraud, M.; Cheillan, D.; Vidal, H.; et al. TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet. Muscle 2012, 2, 2. [Google Scholar] [CrossRef]
  31. Kaur, N.; Gupta, P.; Dutt, V.; Sharma, O.; Gupta, S.; Dua, A.; Injeti, E.; Mittal, A. Cinnamaldehyde attenuates TNF-α induced skeletal muscle loss in C2C12 myotubes regulation of protein synthesis, proteolysis, oxidative stress and inflammation. Arch. Biochem. Biophys. 2024, 753, 109922. [Google Scholar] [CrossRef]
  32. Lee, M.-K.; Choi, Y.H.; Nam, T.-J. Pyropia yezoensis protein protects against TNF-α-induced myotube atrophy in C2C12 myotubes via the NF-κB signaling pathway. Mol. Med. Rep. 2021, 24, 486. [Google Scholar] [CrossRef]
  33. Zhao, Q.; Yang, S.; Wang, J.; Zhou, J.; Xing, S.; Shen, C.; Wang, X.; Yue, Y.; Song, J.; Chen, M.; et al. TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway. Biochem. Biophys. Res. Commun. 2015, 458, 790–795. [Google Scholar] [CrossRef]
  34. Powrózek, T.; Pigoń-Zając, D.; Mazurek, M.; Otieno, M.O.; Rahnama-Hezavah, M.; Małecka-Massalska, T. TNF-α Induced Myotube Atrophy in C2C12 Cell Line Uncovers Putative Inflammatory-Related lncRNAs Mediating Muscle Wasting. Int. J. Mol. Sci. 2022, 23, 3878. [Google Scholar] [CrossRef]
  35. Wu, J.; Lin, S.; Chen, W.; Lian, G.; Wu, W.; Chen, A.; Sagor, M.I.H.; Luo, L.; Wang, H.; Xie, L. TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis. Cell Death Discov. 2023, 9, 76. [Google Scholar] [CrossRef] [PubMed]
  36. Dogra, C.; Changotra, H.; Mohan, S.; Kumar, A. Tumor Necrosis Factor-like Weak Inducer of Apoptosis Inhibits Skeletal Myogenesis through Sustained Activation of Nuclear Factor-κB and Degradation of MyoD Protein. J. Biol. Chem. 2006, 281, 10327–10336. [Google Scholar] [CrossRef] [PubMed]
  37. Geromella, M.S.; Braun, J.L.; Fajardo, V.A. Measuring SERCA-mediated calcium uptake in mouse muscle homogenates. STAR Protoc. 2023, 4, 101987. [Google Scholar] [CrossRef] [PubMed]
  38. Dominguez, L.J.; Barbagallo, M.; Lauretani, F.; Bandinelli, S.; Bos, A.; Corsi, A.M.; Simonsick, E.M.; Ferrucci, L. Magnesium and muscle performance in older persons: The InCHIANTI study1–3. Am. J. Clin. Nutr. 2006, 84, 419–426. [Google Scholar] [CrossRef]
  39. Nielsen, F.H. Magnesium deficiency and increased inflammation: Current perspectives. J. Inflamm. Res. 2018, 11, 25–34. [Google Scholar] [CrossRef]
  40. De Oliveira, A.R.S.; Cruz, K.J.C.; Severo, J.S.; Morais, J.B.S.; De Freitas, T.E.C.; Araújo, R.S.; Marreiro, D.D.N. Hypomagnesemia and its relation with chronic low-grade inflammation in obesity. Front. Public Health 2017, 63, 156–163. [Google Scholar] [CrossRef]
Figure 1. Mg2+ availability affects myotube differentiation. (A) C2C12 cells were seeded in duplicate into 60 mm Petri dishes in media containing low (0.1 mM, yellow) or normal (0.8 mM, purple) Mg2+ concentrations. Cells were counted every 24 h. * p < 0.05 by unpaired Student’s t-test. (BD) C2C12 myoblasts were grown to confluence and differentiated in media containing low (0.1 mM, yellow), normal (0.8 mM, purple) or high (5 mM, green) Mg2+ concentrations, as detailed in Section 4. Differentiated myotubes were visualized under an optical microscope (10× magnification), and analyzed using ImageJ software. (B) Representative images of differentiated myotubes. (C) Number of myotubes per microscopic field (mean ± SD) from a representative experiment; three independent fields were analyzed per experiment. (D) Myotube area (mean ± SD) from a representative experiment; 10 myotubes were measured in three independent fields. ** p < 0.01; *** p < 0.001; **** p < 0.0001; statistical significance was determined by ANOVA followed by Bonferroni’s post-hoc test. All experiments were performed independently three times.
Figure 1. Mg2+ availability affects myotube differentiation. (A) C2C12 cells were seeded in duplicate into 60 mm Petri dishes in media containing low (0.1 mM, yellow) or normal (0.8 mM, purple) Mg2+ concentrations. Cells were counted every 24 h. * p < 0.05 by unpaired Student’s t-test. (BD) C2C12 myoblasts were grown to confluence and differentiated in media containing low (0.1 mM, yellow), normal (0.8 mM, purple) or high (5 mM, green) Mg2+ concentrations, as detailed in Section 4. Differentiated myotubes were visualized under an optical microscope (10× magnification), and analyzed using ImageJ software. (B) Representative images of differentiated myotubes. (C) Number of myotubes per microscopic field (mean ± SD) from a representative experiment; three independent fields were analyzed per experiment. (D) Myotube area (mean ± SD) from a representative experiment; 10 myotubes were measured in three independent fields. ** p < 0.01; *** p < 0.001; **** p < 0.0001; statistical significance was determined by ANOVA followed by Bonferroni’s post-hoc test. All experiments were performed independently three times.
Ijms 26 09912 g001
Figure 2. Mg2+ availability affects Ca2+ release from the SR. C2C12 myoblasts were grown to confluence in glass-bottom microscopy dishes and induced to differentiate in media containing low (0.1 mM, yellow), normal (0.8 mM, purple) or high (5 mM, green) Mg2+ concentrations, as detailed in Section 4. Intracellular Ca2+ concentration was monitored by live confocal imaging in Fluo-4-loaded myotubes. Depolarization was induced at t = 15 s with 50 mM KCl, and single-cell fluorescence changes were quantified by image analysis. (A) Time course of the mean relative increase in intracellular Ca2+ levels (ΔF/F) ± standard error (SE) from a representative experiment is reported; 10 myotubes were analyzed per experiment. (B) The mean maximum amplitude of Ca2+ release (peak ΔF/F) ± standard error (SE) is shown for a representative experiment. Each experiment was repeated independently three times. * p < 0.05, significance was determined by ANOVA followed by Bonferroni’s post-hoc test.
Figure 2. Mg2+ availability affects Ca2+ release from the SR. C2C12 myoblasts were grown to confluence in glass-bottom microscopy dishes and induced to differentiate in media containing low (0.1 mM, yellow), normal (0.8 mM, purple) or high (5 mM, green) Mg2+ concentrations, as detailed in Section 4. Intracellular Ca2+ concentration was monitored by live confocal imaging in Fluo-4-loaded myotubes. Depolarization was induced at t = 15 s with 50 mM KCl, and single-cell fluorescence changes were quantified by image analysis. (A) Time course of the mean relative increase in intracellular Ca2+ levels (ΔF/F) ± standard error (SE) from a representative experiment is reported; 10 myotubes were analyzed per experiment. (B) The mean maximum amplitude of Ca2+ release (peak ΔF/F) ± standard error (SE) is shown for a representative experiment. Each experiment was repeated independently three times. * p < 0.05, significance was determined by ANOVA followed by Bonferroni’s post-hoc test.
Ijms 26 09912 g002
Figure 3. Mg2+ availability impairs intracellular Ca2+ store refilling. C2C12 myoblasts were grown to confluence in glass-bottom microscopy dishes and induced to differentiate in media containing low (0.1 mM, yellow), normal (0.8 mM, purple) or high (5 mM, green) Mg2+ concentrations, as detailed in Section 4. Intracellular Ca2+ concentration was monitored by live confocal imaging in Fluo-4-loaded myotubes. Depolarization was triggered by 50 mM KCl stimulation applied three consecutive times, each separated by a 10-min recovery period. Single-cell fluorescence changes were quantified by image analysis. The mean maximum amplitude of Ca2+ release (peak ΔF/F) ± SE during each stimulation is shown for a representative experiment; 10 myotubes were analyzed per experiment and each experiment was repeated independently three times. * p < 0.05, statistical significance was determined by ANOVA followed by Bonferroni’s post-hoc test.
Figure 3. Mg2+ availability impairs intracellular Ca2+ store refilling. C2C12 myoblasts were grown to confluence in glass-bottom microscopy dishes and induced to differentiate in media containing low (0.1 mM, yellow), normal (0.8 mM, purple) or high (5 mM, green) Mg2+ concentrations, as detailed in Section 4. Intracellular Ca2+ concentration was monitored by live confocal imaging in Fluo-4-loaded myotubes. Depolarization was triggered by 50 mM KCl stimulation applied three consecutive times, each separated by a 10-min recovery period. Single-cell fluorescence changes were quantified by image analysis. The mean maximum amplitude of Ca2+ release (peak ΔF/F) ± SE during each stimulation is shown for a representative experiment; 10 myotubes were analyzed per experiment and each experiment was repeated independently three times. * p < 0.05, statistical significance was determined by ANOVA followed by Bonferroni’s post-hoc test.
Ijms 26 09912 g003
Figure 4. Mg2+ availability affects myotube resistance to inflammatory stimuli. C2C12 myoblasts were grown to confluence and induced to differentiate in media containing low (0.1 mM), normal (0.8 mM) or high (5 mM) Mg2+ concentrations, as detailed in Section 4. After 7 days, differentiated myotubes were either left untreated or exposed to TNF-α (25 ng/mL) for further 24 h. Myotubes obtained under the three Mg2+ conditions, with or without TNF-α treatment, were visualized at an optical microscope (10× magnification), and analyzed using ImageJ software on day 8. (A) Representative images of control (upper panels) and TNF-α treated (lower panels) myotubes under the indicated Mg2+ conditions. (B) Number of myotubes per microscopic field (mean ± SD) from a representative experiment (n = 3); three independent fields were analyzed per experiment. (C) Mean myotube area (mean ± SD) from a representative experiment (n = 3); for each condition, 10 myotubes were measured in three independent fields. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; statistical significance was determined by ANOVA followed by Bonferroni’s post-hoc test. (D) Myostatin expression in myotubes differentiated under the indicated Mg2+ conditions, with or without TNF-α treatment, was analyzed by Western blot. β-actin was used as a loading control. A representative blot is shown (n = 2).
Figure 4. Mg2+ availability affects myotube resistance to inflammatory stimuli. C2C12 myoblasts were grown to confluence and induced to differentiate in media containing low (0.1 mM), normal (0.8 mM) or high (5 mM) Mg2+ concentrations, as detailed in Section 4. After 7 days, differentiated myotubes were either left untreated or exposed to TNF-α (25 ng/mL) for further 24 h. Myotubes obtained under the three Mg2+ conditions, with or without TNF-α treatment, were visualized at an optical microscope (10× magnification), and analyzed using ImageJ software on day 8. (A) Representative images of control (upper panels) and TNF-α treated (lower panels) myotubes under the indicated Mg2+ conditions. (B) Number of myotubes per microscopic field (mean ± SD) from a representative experiment (n = 3); three independent fields were analyzed per experiment. (C) Mean myotube area (mean ± SD) from a representative experiment (n = 3); for each condition, 10 myotubes were measured in three independent fields. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; statistical significance was determined by ANOVA followed by Bonferroni’s post-hoc test. (D) Myostatin expression in myotubes differentiated under the indicated Mg2+ conditions, with or without TNF-α treatment, was analyzed by Western blot. β-actin was used as a loading control. A representative blot is shown (n = 2).
Ijms 26 09912 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Pietropaolo, G.; Castiglioni, S.; Maier, J.A.; Wolf, F.I.; Trapani, V. Magnesium Preserves Calcium Homeostasis and Contributes to Protect Myotubes from Inflammation-Induced Damage. Int. J. Mol. Sci. 2025, 26, 9912. https://doi.org/10.3390/ijms26209912

AMA Style

Pietropaolo G, Castiglioni S, Maier JA, Wolf FI, Trapani V. Magnesium Preserves Calcium Homeostasis and Contributes to Protect Myotubes from Inflammation-Induced Damage. International Journal of Molecular Sciences. 2025; 26(20):9912. https://doi.org/10.3390/ijms26209912

Chicago/Turabian Style

Pietropaolo, Giuseppe, Sara Castiglioni, Jeanette A. Maier, Federica I. Wolf, and Valentina Trapani. 2025. "Magnesium Preserves Calcium Homeostasis and Contributes to Protect Myotubes from Inflammation-Induced Damage" International Journal of Molecular Sciences 26, no. 20: 9912. https://doi.org/10.3390/ijms26209912

APA Style

Pietropaolo, G., Castiglioni, S., Maier, J. A., Wolf, F. I., & Trapani, V. (2025). Magnesium Preserves Calcium Homeostasis and Contributes to Protect Myotubes from Inflammation-Induced Damage. International Journal of Molecular Sciences, 26(20), 9912. https://doi.org/10.3390/ijms26209912

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop